NASH NATiV3 Study

Ages

18 - 75

Location

Columbus, OH

Compensation

Up to $2,200

NASH Trials in Columbus

Centricity Research is currently participating in the NASH NATiV3 study at our Columbus, Ohio location. NASH (Non-Alcoholic SteatoHepatitis) is the form of liver disease that is triggered by what has come to be known as the “Western diet”, characterized especially by high-fat, high-sugar, and processed foods. Among the effects of a prolonged Western diet is fat accumulation in liver cells (steatosis) which is described as Non-Alcoholic Fatty Liver Disease (NAFLD) and can predispose cells to injury.

Enroll Now

NASH NATiV3 Study

The primary objective of the NATiV3 clinical study is to evaluate the long-term effectiveness and safety of an investigational oral drug in the treatment of non-alcoholic steatohepatitis (NASH). You may be eligible to participate if you:

  • Are at least 18 years old
  • Cannot have known non-NASH liver diseases including:
    • Autoimmune diseases
    • Drug induced liver disease
    • Alcoholic liver disease
    • HIV
    • Active Hepatitis B or C

We now offer individuals with known risk factors of Non-Alcoholic Fatty Liver Disease (NAFLD) a free Fibroscan screening.

Ready to Volunteer?

Volunteer today to see if you qualify for our NASH NATiV3 clinical research study. Qualified volunteers may be compensated for time and travel.

Enroll Now